Tissue Regenix | Sustainability Performance
Tissue Regenix specializes in regenerative medicine, focusing on developing and commercializing technologies for tissue repair and regeneration. The company serves healthcare sectors by providing innovative treatment options.
2006
United Kingdom
51 - 200 employees
Medical Device
$25M - 100M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4470
Overallⓘ#622
in United Kingdomⓘ#66
in Medical DeviceⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
- Tissue Regenix's products are derived from animal tissues raising procurement ethics considerations.
